Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viral Transfer Technology
  • Published:

Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element

Abstract

The development of lentiviral vectors that use Rev-independent mechanisms of nuclear export for their genomic RNA could facilitate the construction of novel anti-HIV vectors. We have improved the titers of Rev-independent lentiviral vectors having the SRV-1 CTE by mutating the major splice donor and acceptor sites present in the vector and by relocalization of the CTE sequences adjacent to the HIV-1 3′LTR. These two modifications have additive beneficial effects on vector titers and packaging efficiency. Packaging these CTE+ vectors expressing marker genes with a Rev-dependent HIV-1 helper vector yields higher titers than are obtained using a Rev-dependent lentiviral vector.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Poeschla E, Corbeau P, Wong-Staal F . Development of HIV vectors for anti-HIV gene therapy Proc Natl Acad Sci USA 1996 93: 11395–11399

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Corbeau P, Wong-Staal F . Anti-HIV effects of HIV vectors Virology 1998 243: 268–274

    Article  CAS  PubMed  Google Scholar 

  3. Dropulic B, Hermankova M, Pitha PM . A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread Proc Natl Acad Sci USA 1996 93: 11103–11108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. An DS et al. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication J Virol 1999 73: 7671–7677

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Bukovsky AA, Song JP, Naldini L . Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells J Virol 1999 73: 7087–7092

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Malim MH, Bohnlein S, Hauber J, Cullen BR . Functional dissection of the HIV-1 Rev trans-activator – derivation of a trans-dominant repressor of Rev function Cell 1989 58: 205–214

    Article  CAS  PubMed  Google Scholar 

  7. Ragheb JA et al. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics AIDS Res Hum Retrovir 1995 11: 1343–1353

    Article  CAS  PubMed  Google Scholar 

  8. Gasmi M et al. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors J Virol 1999 73: 1828–1834

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Kim VN, Mitrophanous K, Kingsman SM, Kingsman AJ . Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1 J Virol 1998 72: 811–816

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Srinivasakumar N, Schuening FG . A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery J Virol 1999 73: 9589–9598

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Srinivasakumar N et al. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines J Virol 1997 71: 5841–5848

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Rizvi TA, Schmidt RD, Lew KA, Keeling ME . Rev/RRE-independent Mason–Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay Virology 1996 222: 457–463

    Article  CAS  PubMed  Google Scholar 

  13. Zolotukhin AS, Valentin A, Pavlakis GN, Felber BK . Continuous propagation of RRE(−) and Rev(−)RRE(−) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes J Virol 1994 68: 7944–7952

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Mautino MR, Ramsey WJ, Reiser J, Morgan RA . Modified HIV-based lentiviral vectors display decreased sensitivity to transdominant Rev Hum Gene Ther 2000 11: 895–908

    Article  CAS  PubMed  Google Scholar 

  15. Naldini L et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector Proc Natl Acad Sci USA 1996 93: 11382–11388

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ernst RK, Bray M, Rekosh D, Hammarskjold ML . A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA Mol Cell Biol 1997 17: 135–144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Rizvi TA, Schmidt RD, Lew KA . Mason–Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner Virology 1997 236: 118–129

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mautino, M., Keiser, N. & Morgan, R. Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element. Gene Ther 7, 1421–1424 (2000). https://doi.org/10.1038/sj.gt.3301262

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301262

Keywords

This article is cited by

Search

Quick links